These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9217356)

  • 1. Relapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
    Shetty VP; Antia NH
    Lepr Rev; 1997 Jun; 68(2):162-6. PubMed ID: 9217356
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN; Kumar S; Jain S; Bhattacharya SN
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic prospects for paucibacillary leprosy.
    Katoch K
    Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
    [No Abstract]   [Full Text] [Related]  

  • 4. Leprosy in a preschool child--a case report.
    Arora SK
    J Indian Med Assoc; 2007 Mar; 105(3):140. PubMed ID: 17824468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of borderline tuberculoid Hansen's disease with tuberculosis verrucosa cutis in a child--a rare case.
    Ravindra K; Sugareddy ; Ramachander T
    Indian J Lepr; 2010; 82(2):91-3. PubMed ID: 21434512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulnar abscess: 4 months after release from control with paucibacillary-multidrug therapy.
    Darius EJ; Selvasekar A; Mani MN; Jesudasan K
    Lepr Rev; 1997 Jun; 68(2):173-4. PubMed ID: 9217358
    [No Abstract]   [Full Text] [Related]  

  • 9. Lupus vulgaris and borderline tuberculoid leprosy: an interesting co-occurrence.
    Rao GR; Sandhya S; Sridevi M; Amareswar A; Narayana BL;
    Indian J Dermatol Venereol Leprol; 2011; 77(1):111. PubMed ID: 21220903
    [No Abstract]   [Full Text] [Related]  

  • 10. Facial reversal reaction: a dermatological emergency.
    Marzano AV; Tosi D; Cusini M; Nunzi E; Massone C; Crosti C
    J Dermatol; 2012 Feb; 39(2):203-5. PubMed ID: 21951390
    [No Abstract]   [Full Text] [Related]  

  • 11. Borderline tuberculoid leprosy developing in a pure neuritic case.
    Porichha D; Mahapatra DC
    Indian J Lepr; 1991; 63(2):235-7. PubMed ID: 1783794
    [No Abstract]   [Full Text] [Related]  

  • 12. Dapsone syndrome: an incomplete form.
    Jaswal R; Thami GP; Kanwar AJ
    Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
    [No Abstract]   [Full Text] [Related]  

  • 13. A recurrent case of BT leprosy with widely spread skin lesions showing a histopathology of indeterminate group after 4.5-years irregular treatment, Bangladesh.
    Ishida Y; Ozaki M; Picorini L; Guglielmelli E
    Nihon Hansenbyo Gakkai Zasshi; 1999 Nov; 68(3):195-9. PubMed ID: 10659615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A papulosquamous eruption in a 12-year-old cambodian boy.
    Rabinowitz LG; Yuengel C; Honig PJ; Solomon AR
    Pediatr Dermatol; 1989 Jun; 6(2):152-4. PubMed ID: 2748476
    [No Abstract]   [Full Text] [Related]  

  • 15. Leucocytopenia after rifampicin and ofloxacin therapy in leprosy.
    Vijayakumaran P; Manimozhi N; Jesudasan K; Arunthathi S; Jacob M; Samuel P
    Lepr Rev; 1997 Mar; 68(1):10-5. PubMed ID: 9121326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
    Shetty VP; Wakade A; Antia NH
    Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinguishing between relapse and late reversal reaction in multidrug (MDT)-treated BT leprosy.
    Waters MF
    Lepr Rev; 2001 Sep; 72(3):250-3. PubMed ID: 11715270
    [No Abstract]   [Full Text] [Related]  

  • 19. "Flu" syndrome on monthly rifampin dose; first case reported from Yemen.
    al-Samie AR; al-Qubati Y
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):574-6. PubMed ID: 8642225
    [No Abstract]   [Full Text] [Related]  

  • 20. Autochthonous borderline tuberculoid leprosy in a man from Florida.
    Villada G; Zarei M; Romagosa R; Forgione P; Fabbrocini G; Romanelli P
    Lepr Rev; 2016 Mar; 87(1):101-3. PubMed ID: 27255063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.